130 related articles for article (PubMed ID: 28564535)
1. Clinical Relevance of Donor-Specific IgM Antibodies in HLA Incompatible Renal Transplantation: A Retrospective Single-Center Study.
Babu A; Andreou A; Briggs D; Krishnan N; Higgins R; Mitchell D; Barber T; Daga S
Clin Transpl; 2016; 32():173-179. PubMed ID: 28564535
[TBL] [Abstract][Full Text] [Related]
2. Low-MFI (median fluorescence intensity) pre-transplant DSA (donor specific antibodies) leading to anamnestic antibody mediated rejection in live-related donor kidney transplantation.
Chauhan R; Tiwari AK; Aggarwal G; Gowri Suresh L; Kumar M; Bansal SB
Transpl Immunol; 2023 Dec; 81():101931. PubMed ID: 37730185
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of serial monitoring of donor-specific antibodies in pediatric and adult intestinal/multivisceral transplant recipients.
Klein K; Keck M; Langewisch E; Merani S; Hitchman K; Leick M
Pediatr Transplant; 2024 Feb; 28(1):e14638. PubMed ID: 37942670
[TBL] [Abstract][Full Text] [Related]
4. Including the liver in the visceral allograft: Impact on donor-specific anti-HLA antibodies and long-term outcomes.
Abele D; Gäbel M; Oltean M; Varkey J; Mölne J; Ekwall N; Borg H; Jacobsson H; Holgersson J; Herlenius G
Hum Immunol; 2024 Mar; 85(2):110767. PubMed ID: 38418315
[TBL] [Abstract][Full Text] [Related]
5. The Clinical Utility of Post-Transplant Monitoring of Donor-Specific Antibodies in Stable Renal Transplant Recipients: A Consensus Report With Guideline Statements for Clinical Practice.
van den Broek DAJ; Meziyerh S; Budde K; Lefaucheur C; Cozzi E; Bertrand D; López Del Moral C; Dorling A; Emonds MP; Naesens M; de Vries APJ;
Transpl Int; 2023; 36():11321. PubMed ID: 37560072
[TBL] [Abstract][Full Text] [Related]
6. A2/A2B to B kidney transplantation outcomes: A single center 7-year experience.
El Chediak A; Shawar S; Fallahzadeh MK; Forbes R; Schaefer HM; Feurer ID; Rega S; Triozzi JL; Shaffer D
Clin Transplant; 2024 Apr; 38(4):e15295. PubMed ID: 38545909
[TBL] [Abstract][Full Text] [Related]
7. IgM marks persistent IgG anti-human leukocyte antigen antibodies in highly sensitized heart transplant patients.
Li F; Gragert L; Giovanni Biagini D; Patel JK; Kobashigawa JA; Trück J; Rodriguez O; Watson CT; Gibb DR; Zhang X; Kransdorf EP
J Heart Lung Transplant; 2024 Feb; 43(2):314-323. PubMed ID: 37793509
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the Clinical Relevance of Antibodies against Non-Human Leukocyte Antigen in Kidney Transplantation.
Bhutani S; Harris S; Carr M; Russell-Lowe M; Worthington J; Wu HHL; Chinnadurai R; Poulton K
Antibodies (Basel); 2024 Jun; 13(2):. PubMed ID: 38920968
[No Abstract] [Full Text] [Related]
9. Impact of Preformed Donor-Specific Anti-HLA-Cw and Anti-HLA-DP Antibodies on Acute Antibody-Mediated Rejection in Kidney Transplantation.
Laboux T; Lenain R; Visentin J; Flahaut G; Chamley P; Provôt F; Top I; Kerleau C; Labalette M; Choukroun G; Couzi L; Blancho G; Hazzan M; Maanaoui M
Transpl Int; 2023; 36():11416. PubMed ID: 38076227
[TBL] [Abstract][Full Text] [Related]
10. Antibody-mediated rejection with detection of de novo donor-specific anti-human leukocyte antigen Class II antibodies after lung transplantation: Problems in diagnosis, treatment and monitoring on a case report basis.
Dukat-Mazurek A; Stachowicz-Chojnacka K; Karolak W; Zielińska H; Moszkowska G; Kałęka P; Wojarski J; Żegleń S
Transpl Immunol; 2023 Dec; 81():101918. PubMed ID: 37598914
[TBL] [Abstract][Full Text] [Related]
11. Donor specific antibody surveillance among pediatric kidney transplant programs: A report from the improving renal outcome collaborative.
Steinbach EJ; Barletta GM; Patel HP; Hooper DK; Garro R; Harshman LA
Pediatr Transplant; 2023 May; 27(3):e14498. PubMed ID: 36898856
[TBL] [Abstract][Full Text] [Related]
12. Examining the Role for Donor-specific Antibody Testing in Simultaneous Liver-kidney Transplantation: A Single-center Analysis of Outcomes.
Das A; Rocque B; Remulla D; Raza M; Barbetta A; Bangerth S; Goldbeck C; Maw TT; Kim J; Kwon Y; Emamaullee J
Transplantation; 2023 May; 107(5):1115-1123. PubMed ID: 36398988
[TBL] [Abstract][Full Text] [Related]
13. Determination of the clinical relevance of donor epitope-specific HLA-antibodies in kidney transplantation.
Kardol-Hoefnagel T; Senejohnny DM; Kamburova EG; Wisse BW; Reteig L; Gruijters ML; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas MC; Spierings E; Hack CE; van Reekum FE; van Zuilen AD; Verhaar MC; Bots ML; Drop ACAD; Plaisier L; Melchers RCA; Seelen MAJ; Sanders JS; Hepkema BG; Lambeck AJA; Bungener LB; Roozendaal C; Tilanus MGJ; Voorter CE; Wieten L; van Duijnhoven EM; Gelens MACJ; Christiaans MHL; van Ittersum FJ; Nurmohamed SA; Lardy NM; Swelsen W; van der Pant KAMI; van der Weerd NC; Ten Berge IJM; Hoitsma A; van der Boog PJM; de Fijter JW; Betjes MGH; Roelen DL; Claas FH; Bemelman FJ; Senev A; Naesens M; Heidt S; Otten HG
HLA; 2024 Jan; 103(1):e15346. PubMed ID: 38239046
[TBL] [Abstract][Full Text] [Related]
14. Anti-Hla Donor-Specific Antibodies Are Associated to Infection and Not to the Engraftment Rate in Outpatient Haploidentical Hematopoietic Cell Transplantation.
Jaime-Pérez JC; Cruz MLR; Mendoza-Ibarra SI; Moncada-Saucedo NK; Gómez-Almaguer D
Rev Invest Clin; 2023; 75(5):249-258. PubMed ID: 37918011
[TBL] [Abstract][Full Text] [Related]
15. Impact of donor-specific anti-HLA antibody on cardiac hemodynamics and graft function 3 years after pediatric heart transplantation: First results from the CTOTC-09 multi-institutional study.
Webber SA; Chin H; Wilkinson JD; Armstrong BD; Canter CE; Dipchand AI; Dodd DA; Feingold B; Lamour JM; Mahle WT; Singh TP; Zuckerman WA; Rossano JW; Morrison Y; Diop H; Demetris AJ; Bentlejewski C; Mohanakumar T; Odim J; Zeevi A;
Am J Transplant; 2023 Dec; 23(12):1893-1907. PubMed ID: 37579817
[TBL] [Abstract][Full Text] [Related]
16. Tracking Circulating HLA-Specific IgG-Producing Memory B Cells with the B-Cell ImmunoSpot Assay.
Kervella D; Heidt S; Fairchild R; Todryk S; Bestard O
Methods Mol Biol; 2024; 2768():201-209. PubMed ID: 38502395
[TBL] [Abstract][Full Text] [Related]
17. Role of HLA matching and donor specific antibody development in long-term survival, acute rejection and cardiac allograft vasculopathy.
Costa D; Picascia A; Grimaldi V; Amarelli C; Petraio A; Levi A; Di Donato M; Pirozzi AVA; Fiorito C; Moccia G; Gallo A; Strozziero M; Marra C; De Feo M; Cacciatore F; Maiello C; Napoli C
Transpl Immunol; 2024 Apr; 83():102011. PubMed ID: 38403197
[TBL] [Abstract][Full Text] [Related]
18. A Single-Center Analysis of How HLA Mismatch and Donor-Specific Antibodies Affect Short-Term Outcome After Lung Transplantation: A Pilot Study Before a Country-Wide Histocompatibility Study in Japan.
Hirama T; Akiba M; Watanabe T; Watanabe Y; Oishi H; Okada Y
Transplant Proc; 2024 Mar; 56(2):363-368. PubMed ID: 38320866
[TBL] [Abstract][Full Text] [Related]
19. The impact of IdeS (imlifidase) on allo-specific, xeno-reactive, and protective antibodies in a sensitized rhesus macaque model.
DeLaura I; Zikos J; Anwar IJ; Yoon J; Ladowski J; Jackson A; Van Rompay K; Magnani D; Knechtle SJ; Kwun J
Xenotransplantation; 2024; 31(1):e12833. PubMed ID: 37864433
[TBL] [Abstract][Full Text] [Related]
20. Does bortezomib influence pre-transplant desensitization therapy or benefit post-heart transplant outcomes for highly sensitized patients?
Dhillon M; Kobashigawa JA; Kittleson M; Jain R; Patel N; Singer-Englar T; Zhang X; Hakimi M; Aintablian T; Vescio R; Dilibero D; Kransdorf E; Czer L; Nikolova AP; Patel JK
Clin Transplant; 2024 Jan; 38(1):e15165. PubMed ID: 37837612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
